Abstract:The retinoblastoma susceptibility gene (Rb1) is an important tumor suppressor gene during tumorigenesis, which is also involved in multiple physiological processes. including cell cycle, cellular apoptosis and cell differentiation. The interaction between Rb1 and E2F1/DPI plays a pivotal role in the cell cycle regulation and cellular apoptosis. The essential role of Rbl gene in the skeletal muscle has been demonstrated in the Rb1 null mice. in which the myogenic cells went to apoptosis during embryonic development. Biochemical studies have also shown that Rb1 may regulate the transcription activity of myogenic transcription factors (MRFs), thereby promoting myogenic differentiation. MRFs (including MyoD, Myf5. Myf6 and Myog) belong to a superfamily of basic helix-loop-helix (bHLH) transcription factor, which heterodimerize with E proteins and bind to the specific DNA sequence as E-box (CANNTG). Extensive studies have revealed the essential roles of MRFs in the skeletal muscle development, and identified a broad range of downstream skeletal muscle-specific genes. However, it is still not well understood about the mechanisms of the transcriptional regulation of Rb1 during skeletal muscle development. Previous study has reported the murine Rb16 kb promoter, which directed the transgenic reporter expression exclusively to the central and peripheral nervous system, while the transgenic reporter lines were unable to recapitulate Rb1 expression in the somite during murine embryonic development. In the present studies, we have utilized a number of techniques, including bioinformatic analysis, transgenic mice model, transcriptional assays, and mutagenic analysis to investigate the regulatory mechanisms of Rb1 gene expression. Here, we report several interesting discoveries: (1) We have identified the 1.6 kb promoter and 1.7 kb enhancer of the Rb1 gene through bioinformatics analysis. Our further studies have shown the significant synergistic interaction between the promoter and enhancer through transcriptional assays. (2) We have constructed the transgenic reporter vector (1.6 kb promoter-Hsp68-LacZ-1.7 kb enhancer) and generated transgenic Rb 1 -LacZ mouse model through the service of the GemPharmatech Company. Two transgenic Rb1-LacZ reporter lines have been established successfully: #7 and #10. The following LacZ staining analysis has confirmed the LacZ reporter expression in the embryonic somite and adult skeletal muscle (gastrocnemius muscle. soleus, tibialis anterior and extensor digitorum longus). These transgenic studies have demonstrated that the 1.6 kb promoter and 1.7 kb enhancer of Rbl is sufficient to drive the LacZ reporter expression in the somite and adult skeletal muscle. (3) We have examined the functional roles of the four conserved E-box motifs in the 1.6 kb promoter and 1.7 kb enhancer of Rb1 through mutagenesis. Our preliminary studies have revealed that the mutation of these four E-box sites resulted in a significant decrease of the reporter activity during myogenic differentiation. (4) Transcriptional assays have shown that MRFs can transactivate the luciferase reporter harboring the 1.6 kb promoter and 1.7 kb enhancer of Rb1 gene through the NIH 3T3 cells. In summary, our studies have uncovered another regulatory cascade MRFs-Rbl-E2F1/DP1 in the cell apoptosis during skeletal muscle development.

An E2f-Binding Site Mediates Cell-Cycle-Regulated Repression of Mouse B-Myb Transcription

Cell-cycle Regulation of Human B-myb Transcription

Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

C-Myb Regulates Cell Cycle-Dependent Expression of Erbin: an Implication for a Novel Function of Erbin.

Binding of FoxM1 to G2/M Gene Promoters is Dependent Upon B-Myb.

Modulation of E2F Complexes during G0 to S Phase Transition in Human Primary B-lymphocytes

Transcription Regulation by Murine B-myb is Distinct from That by C-Myb.

An E2F site in the 5'-promoter region contributes to serum-dependent up-regulation of the human proliferating cell nuclear antigen gene.

Genome-wide binding analysis unveils critical implication of B-Myb-mediated transactivation in cancers

Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.

The E2F functional analogue SBF recruits the Rpd3(L) HDAC, via Whi5 and Stb1, and the FACT chromatin reorganizer, to yeast G1 cyclin promoters.

Transcriptome regulation and chromatin occupancy by E2F3 and MYC in mice

Structural basis for cell type specific DNA binding of C/EBPβ: The case of cell cycle inhibitor p15INK4b promoter

The identification of the promoter and enhancer of <i>Rb1</i> gene

MEF2C and EBF1 Co-regulate B Cell-Specific Transcription

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

The myb gene family in cell growth, differentiation and apoptosis

C-Myb and Ets Proteins Synergize to Overcome Transcriptional Repression by ZEB.

E2F4 regulates the cell cycle and DNA replication in the silkworm, Bombyx mori

An intermediate Rb–E2F activity state safeguards proliferation commitment